Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by JLGeminion Mar 08, 2011 1:29pm

260 Views

Post# 18252223

RE: RE: RE: Only 23 days to go!

At $13.52, I expect a lot of people will be interested in selling. I plan to buy on margin until the stock is above $10. I do not plan to sell until after the partnership news is out.

Currently, I'm seeing a frustrated buy side manipulation as retail investors wait and hold onto their stocks. At 1:22 ONCY was down 10 cents at $6.22 on 65,709 shares. The bid was 1000 shares at $6.24 with only 200 on the ask of $6.27. On the TSX, ONC is also down a dime at $6.06 on a volume of 28,247. The bid is 3000 shares at $6.06 and again 200 on the ask for $6.08. Yesterday's volumes were 48,602 on the NASDAQ and 42,218 on the TSX.

Bullboard Posts

Three stocks with strong income statements to buy right now